Introduction
Nitric oxide (NO) is produced by an array of cells and is involved in the regulation of physiological events such as in¯ammation, vascular tone and metabolism.
1,2 Depending on the cell type, NO is formed in an enzymatic reaction catalysed by one of three isoforms of NO synthase (NOS). 2 Neuronal NOS (nNOS) and endothelial NOS (eNOS) are constitutively active and produce small amounts of NO following stimuli that raise intracellular Ca 2 concentrations.
The third isoform, inducible NOS (iNOS), is expressed after induction by agents such as cytokines and bacterial lipopolysaccharide. The ®rst clue that NO could have a physiological role in adipose tissue was given in a study by Ribie Áre et al, showing the presence of eNOS and iNOS in white adipose tissue of the rat. 3 We subsequently demonstrated the presence of NOSactivity and iNOS protein also in human subcutaneous (s.c.) adipose tissue and showed that inhibition of NOS resulted in an increased lipolysis. 4 Conversely, addition of NO caused an inhibition of lipolysis in intact adipose tissue in vivo, as well as in isolated fat cells in vitro. Together, these results suggest an important role for NO in the regulation of lipolysis in man. 4 In an extension of these studies we recently demonstrated the presence of eNOS and in signi®cantly lower amounts iNOS mRNA and protein in human s.c. adipose cells and tissue. 5 In line with results from studies on rat tissue, nNOS could not be detected in human adipose tissue.
Gaudiot et al 6 have shown that a subset of synthetic NO donors as well as NO gas affect mainly catecholaminestimulated, but not basal lipolysis on rat adipocytes. In contrast, in human adipose tissue there is an inhibitory effect of NO on both basal and catecholamine-stimulated lipolysis. 4 This indicates important species differences in the action of NO on lipolysis, in rat vs man. It is well established that lipolysis is altered in several conditions, among others obesity. 7 In a recent study, a signi®cant increase in eNOS but not iNOS expression both at the mRNA and protein level was observed in obese vs lean subjects. 5 Taken together, these results led us to speculate that eNOS may have a pathophysiological role in obesity by modulating lipolysis through NO.
Adipose tissue from different regions expresses different subsets of genes and displays distinct metabolic properties. Most importantly, lipolytic rates in omental and s.c. tissue are different. Thus, omental tissue displays a low basal lipolysis while the catecholamine-stimulated lipolysis is increased compared with s.c. tissue. 7 In order to see whether regional differences in basal lipolysis are accompanied by site variations in expression levels of eNOS and iNOS, we investigated the mRNA and protein levels of these NOS isoforms in obese patients where both s.c. and omental adipose tissue was available.
Materials and methods

Subjects
All subjects were otherwise healthy male Caucasians born in Sweden. The study group (ages 28±57 y) consisted of eight obese men. The subjects were undergoing weight reduction surgery with adjustable gastric banding. The study was approved by the Ethics Committee of Karolinska Institutet (Stockholm, Sweden). All subjects gave informed consent to participate in the study.
Tissue
The subjects fasted overnight, and s.c. abdominal and omental adipose tissue (1±2 g) was taken from the surgical wound within 30 min after the start of the operation. Only saline was administered until the tissue pieces were taken. Surgical anesthesia was given as previously described. 8 All tissue pieces were frozen in liquid nitrogen and stored at 770 C for subsequent analysis.
Gene expression RNA preparation, primers, reverse transcription, polymerase chain reaction, and construction of the internal standards (IS) for quantitative competitive reverse transcriptase polymerase chain reaction (RT-PCR) of eNOS, iNOS and 18S rRNA are extensively described elsewhere. 5 Primers were derived from published sequences. 9±11 The quanti®cation of PCR products for iNOS and eNOS was carried out according to Gross et al 12 and as described thoroughly previously. 5 The PCR products for 18S rRNA were resolved on a 3% agarose gel and scanned using a CCD camera (DIANA 1, Fuji Film AB, Stockholm, Sweden). The optical density (OD) of bands on the gel was determined using TINA 2.09G software. The log (OD IS/OD RNA) was plotted as a function of log IS, and the amount of RNA was calculated as described elsewhere. 5 Protein isolation and Western blot analysis Fat tissue specimens from abdominal s.c. and omental tissue were snap-frozen in liquid nitrogen and stored at 770 C. Aliquots ranging from 200 to 600 mg were used to isolate protein as described previously. 5 Protein content in each sample was determined using a kit of reagents from Pierce Biotech. One hundred (eNOS) or 200 (iNOS) mg of total protein were then loaded on polyacrylamide gels and separated by standard SDS±polyacrylamide gel electrophoresis. To control for differences in gel migration, exposure time, antibody incubation etc, samples were run on the same gels and transferred to the same PVDF membranes (Amersham). Blots were blocked overnight in 2.5% non-fat dried milk and probed with antibodies directed against eNOS and iNOS (1:1000, both from Transduction Laboratories, USA). Positive controls were included in all experiments as provided by the manufacturer (Transduction Laboratories, USA), to con®rm antibody speci®city. Secondary antibodies conjugated to horseradish peroxidase were from Sigma (1:5000). Antigen± antibody complexes were detected by chemiluminescence using a kit of reagents from ECL (Amersham, UK) and blots were exposed to high-performance chemiluminescence ®lm (Amersham, UK). Films were scanned and the optical density of each speci®c band analysed using the ImageMaster program and expressed as ODamm 2 a100 mg of total protein.
Lipolysis
Basal lipolysis was determined as described in detail previously. 13 Aliquots of isolated fat cells were prepared from six patients and their average size, volume and weight were determined. Dilute fat cell suspensions (2% vav) were incubated in duplicate for 2 h at 37 C in a Krebs±Ringer phosphate (KRP) buffer (pH7.4) containing bovine albumin (20 gal), glucose (1 mgaml) and ascorbic acid (0.1 mgaml). At the end of incubation, an aliquot of the medium was removed for the analysis of glycerol (lipolysis index) and the amount of glycerol release was related to the number of incubated fat cells (equivalent to basal lipolysis).
Chemicals
The following chemicals were used: 1-ethiyl-3-(3-dimethylaminopropyl) carbodiimide methiodide (EDC methiodide, 
Statistical analysis
Results are presented as means AE s.e.m. Statistical differences were analysed by Mann±Whitney's non-parametric test; P`0.05 was regarded as a signi®cant difference. Statistical differences in lipolysis were analysed by Wilcoxon's nonparametric rank-sum test.
Results
NOS gene expression
Speci®c fragments were ampli®ed for eNOS (116 bp) and iNOS (114 bp) in s.c. and omental tissue, respectively (data not shown). Quanti®cation showed that in all subjects an approximately 30-fold higher mRNA expression was observed for eNOS, as compared to iNOS (Table 1) . However, the expression levels for both eNOS and iNOS were similar in both types of adipose tissue: for eNOS, 6098 AE 1969 amolamg RNA and 6987 AE 2914 amolamg RNA (mean AE s.e.m., P 0.75) in s.c. and omental tissue, respectively; and for iNOS mRNA levels were 227 AE 127 amolamg RNA and 245 AE 162 amolamg RNA (mean AE s.e.m., P 0.8) in s.c. and omental tissue, respectively. To control for non-speci®c changes in gene expression, the gene encoding the ribosomal protein 18S rRNA was used. No changes in the expression of this gene were observed between the two different fat depots (Table 1) .
Levels of eNOS and iNOS protein in adipose tissue
Next, we analysed the expression of eNOS and iNOS protein in both s.c. and omental tissue samples in the same group of individuals. eNOS protein was quanti®ed by gel scanning. In contrast with the mRNA data, an almost 4-fold increase in eNOS protein levels was observed in omental vs s.c. tissue, 7.47 AE 4.11 and 1.88 AE 2.0, respectively (ODamm 2 /100 mg total protein, P 0.0063, Figure 1 ). In agreement with the mRNA data, iNOS protein was expressed at substantially lower levels that were below the detection limit of the present method. When twice the amount (200 mg) of total protein was loaded, a weak expression of iNOS protein could be seen in a subset of the patient samples (Figure 1 , lower lane). The low levels prevented a reliable quantitative measurement, however, there were no apparent differences in iNOS expression between the two types of adipose tissue.
Lipolysis in subcutaneous and omental tissue
In order to compare NOS expression levels to lipolysis rate in different adipose regions, basal lipolysis was determined in the same set of patients. Tissue from six of the eight patients was obtained. Basal lipolysis was measured in isolated adipocytes and corrected for cell number. Lipolysis rates in omental tissue were signi®cantly lower than in s.c. tissue, 5.145 AE 1.657 and 9.752 AE 2.026 mmol of glycerola2 ha10 7 cells, respectively (mean AE s.e.m., P 0.028).
Discussion
In the present study, we report for the ®rst time on regional differences in NOS expression in human adipose tissue. This could be of pathophysiological importance bearing in mind 4, 6 and the wellknown metabolic differences between different fat depots. 7 Using a recently described quantitative RT-PCR for NOS mRNA we present gene expression data for endothelial and inducible NOS mRNA in s.c. and omental human fat tissue.
We were able to demonstrate mRNA for both eNOS and iNOS and, in accordance with previous results, we observed an approximately 30-fold higher eNOS as compared to iNOS gene expression. 5 More importantly, however, no signi®cant difference in NOS mRNA expression could be detected between the two types of adipose tissue.
We also demonstrated eNOS and low levels of iNOS protein in the same human adipose tissue regions by means of Western blot analysis. In accordance with our previous results, 5 iNOS was expressed at low levels in a subset of patients but no difference in expression could be seen in the two fat depots. Still, these data do not exclude minor site differences in iNOS expression, which are undetectable with the current analysis method. Moreover, this study was performed on non-stimulated tissue. It remains to be established whether cytokine or LPS-stimulated adipose tissue displays regional differences in iNOS expression.
In contrast to the ®ndings at the mRNA level, eNOS protein was signi®cantly more expressed in omental compared with s.c. tissue. Since these analyses were performed on whole tissue protein extracts and omental tissue is more extensively vascularized compared with s.c. tissue, it is possible that the increased levels of eNOS in omental tissue were contributed to by the vascularized stroma. In fact, the classical localization of eNOS is in the endothelial cells. However, we have recently demonstrated similar expression levels of eNOS mRNA and protein in adipose tissue and isolated fat cells, 5 suggesting that eNOS in human adipose tissue is to a large extent derived from the adipocytes themselves and not from endothelial cells contaminating the preparation. Moreover, if contamination by stromal cells would have been substantial, one would also have expected to see differences in eNOS mRNA and possibly even iNOS expression. We believe that the difference between eNOS mRNA and protein expression could be the result of posttranscriptional mechanisms in the adipocytes, possibly by enhanced eNOS protein stability, decreased degradation andaor other mechanisms, which remain to be resolved. Interestingly, a recent study on hypoxia in endothelial cells has shown a speci®c increase in eNOS protein and activity without a concomitant increase in eNOS mRNA.
14 Thus, selective regulation of eNOS protein content may be of functional importance in several different cell systems. Considering the fact that discordant results on mRNA and protein expression are sometimes seen, these results also underline the importance of studying both gene and protein expression in quantitative studies.
Inhibition of NOS, using the NOS-inhibitor L-NMMA, has been shown to increase basal lipolysis in normal subjects in vivo indicating a role for NO in regulation of the lipolytic process. 4 Studies on fat depots from different regions of obese individuals have shown that s.c. adipose tissue shows an increased basal lipolysis rate in comparison with omental tissue, while omental tissue displays an increased catecholamine-stimulated lipolysis. 7 In a previous work, we demonstrated that NO gas and NO obtained from nitroglycerine could reduce basal and isoprenaline-induced lipolysis in isolated fat cells. 4 In this study we show increased eNOS protein levels in omental tissue of obese individuals. This in turn might raise local NO production and be a factor responsible for the decreased basal lipolysis in omental compared to s.c. tissue observed herein (Table 1) and elsewhere. 7 Moreover, the fact that stimulated lipolysis is enhanced in omental compared to s.c. tissue 7 suggest that NO (produced by eNOS) may be of less importance for regulation of catecholamine-stimulated lipolysis. It is tempting to speculate that catecholamine-induced signals are able to override a tonic inhibition of basal lipolysis by NO. We admit that this speculation needs to be supported by more direct studies of NO production and lipolysis. Most importantly, eNOS activity has to be measured directly. In preliminary experiments we have measured nitrateanitrite production in isolated adipocytes by a sensitive capillary electrophoresis method. However, this method is not sensitive enough to obtain reliable results. A more direct approach would be to measure NO directly. Unfortunately, the limited amount of adipose tissue obtained in the surgical Figure 1 Expression of eNOS and iNOS protein in subcutaneous and omental tissue from obese subjects. Total protein extracts from subcutaneous (s.c.) or omental fat tissue were obtained from eight (1±8) obese subjects. One hundred (upper lane) or 200 (lower lane) mg of total protein were transferred to PVDF-membranes by Western blotting. Blots were probed with antibodies directed against eNOS and iNOS as indicated by the arrows. Positive controls for eNOS (human endothelial cells) and iNOS (cytokine stimulated macrophages) were included as indicated. Note that the levels of iNOS protein are low (compare with positive control) and only detectable in patients 1±3. In contrast, eNOS is easily detectable in all samples although at varying levels. The expression of eNOS was consistently higher in omental tissue which was con®rmed by densitometric scanning (see Table 1 ).
eNOS in human adipose tissue M Ryde Ân et al procedures prevents us from performing more extensive NO studies. In summary, the present study demonstrates regional differences in eNOS expression in human adipose tissue from obese subjects. The protein expression of eNOS but not iNOS is signi®cantly higher in omental than s.c. tissue, which may be due to post-transcriptional site variations in eNOS expression. It is possible that the comparably lower basal lipolysis in omental compared with s.c. adipose tissue in obesity may be caused by increased eNOS protein levels in omental adipose tissue. Further studies are needed to evaluate whether changes in eNOS protein expression and basal lipolysis are also observed in lean subjects.
